論文（2007）

英文原著

• Kawata E, Kuroda J, Wada K, Kamiuchi K, Nakayama-Harusato I, Kimura S, Maekawa T, Kitagawa Y. Hypereosinophilic syndrome accompanied with Buerger’s disease-like femoral arterial occlusion. Int Med 46: 1919-1922, 2007.
• Kuroda J, Kimura S, Strasser A, Andreeff M, O’Reilly LA, Ashihara E, Kamitsuji Y, Yokota A, Kawata E, Takeuchi M, Tanaka R, Tabe Y, Taniwaki M, Maekawa T. Apoptosis-based dual molecular targeting by INNO-406, a second generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of anti-apoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia. Cell Death Diff 14: 1667-1677, 2007.
• Munaka T, Abe H, Kanai M, Sakamoto T, Nakanishi H, Shoji S, Kimura S, Maekawa T, Murakami A. Real-time monitoring of antibody secretion from B-cells on a microchip stimulated with a minute amount of mitogen. The Analyst 132: 512-514, 2007.
• Wada M, Kawahito Y, Kimura S, Kohno M, Ishino H, Kimura M, Omoto A, Yamamoto A, Hamaguchi M, Tsubouchi Y, Ashihara E, Tokunaga D, Hojo T, Maekawa T, Yoshikawa Y. Small interfering RNA targeting PLK-1 induces the apoptosis of synoviocytes of rheumatoid arthritis. Biochem Biophys Res Commun 357: 353-359, 2007.
• Uchida R, Ashihara E, Sato K, Kimura S, Kuroda J, Takeuchi M, Taniguchi K, Okamoto M, Shimura K, Kiyono Y, Shimazaki C, Taniwaki M, Maekawa T. γδT cells kill myeloma cell by sensing mevalonate metabolites and ICAM-1 molecules on cell surface. Biochem Biophys Res Commun 354: 613-618, 2007.
• Yurugi K, Kimura S, Ashihara E, Tsuji H, Kawata E, Kamitsuji Y, Hishida R, Takegawa M, Egawa H, Maekawa T. Rapid and Accurate Measurement of Anti-A/B IgG Antibody in ABO-unmatched Living Donor Liver Transplantation by Surface Plasmon Resonance. Transfusion Med 7: 97-106, 2007.
• Ashihara E, Tsuji H, Sakashita Y, Haga H, Yurugi K, Kimura S, Egawa H, Manabe T, Uemoto S, Maekawa T. Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival. Transplantation 83: 506-509, 2007.
• Horie N, Murata H, Kimura S, Takeshita H, Sakabe T, Matsui T, Maekawa T, Kubo T, Fushiki S. Combined effects of a third-generation bisphosphonate, zoledronic acid with other anti-cancer agents against osteosarcoma. Brit J Cancer 96: 255-261, 2007.
• Yokota A, Kimura S, Masuda S, Ashihara E, Kuroda J, Sato K, Kamitsuji Y, Kawata E, Deguchi Y, Urasaki Y, Terui Y, Ruthardt M, Ueda T, Hatake K, Inui K, Maekawa T: INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system and cyclosporine A augments its in vivo activity. Blood 109: 306-314, 2007.
• K Teye, Arima N, Nakamura Y, Sakamoto K, Sueoka E, Kimura H, Tsuneoka M: Expression of Myc target gene mina53 in subtypes of human lymphoma. Oncol Rep 18: 841-848, 2007.
• Ide M, Fukushima N, Hisatomi T, Tsuneyoshi N, Tanaka M, Yokoo M, Tomimasu R, Funai N, Sueoka E: Non-germinal cell phenotype and bcl-2 expression primary adrenal diffuse large B-cell lymphoma. Leuk Lymphoma 48: 2244-2246, 2007.
• K Tobinai, K Takeyama, F Arima, T Kobayashi, S Hanada, M Kasai, S Ogura, E Sueoka, K Mukai, K Tajima, H Fukuda, S Shirakawa, T Hotta, S Masanori: Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group Study 9004. Cancer Sci 98: 1350-1357, 2007.
• Sadakane Y, Zaitsu M, Nishi M, Sugita K, Mizutani S, Matsuzaki A, Sueoka E, Hamasaki Y, Ishii E: Expression of Myc target gene mina53 in subtypes of human lymphoma. Br J Haematol 136: 297-300, 2007.
• Sueoka N, Sato A, Eguchi H, Komiya K, Sakuragi T, Mitsuoka M, Satoh T, Hayashi S, Nakachi K, Sueoka E: Mutation profile of EGFR gene detected by denaturing high-performance liquid chromatography in Japanese lung cancer patients. J Cancer Res Clin Oncol 133: 93-102, 2007.
• Haruta Y, Koarada S, Tada Y, Mitamura M, Ohta A, Fukuoka M, Hayashi S, Nagasawa K: High expression of Toll-like receptor 4 on CD14+ monocytes in acute infectious diseases. Scand J Infect Dis 39: 577-583, 2007.

英文著書

• Kuroda J, Kimura S. The role of BH3-only proteins in cancer and anti-cancer therapeutics. Cell Apoptosis Research Trends, New York: Nova Publisher, 2007; 1-39.

英文総説

• Maekawa T, Ashihara E, Kimura S. The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome positive leukemias. Int J Clin Oncol 12: 327-340, 2007.
• Yuasa T, Kimura S, Ashihara E, Habuchi T, Maekawa T. Zoledronic Acid –a multiplicity of anti-cancer action-. Current Med Chem 14, 2126-2135, 2007.
• Niwa T, Asaki T, Kimura S. Bcr-Abl/Lyn Dual Tyrosine Kinase Inhibitor, INNO-406. Analytical Chemistry Insights 2: 93-106, 2007.

邦文原著

• 小林裕、室谷佳秀、澤井奈々、赤荻照章、迫雅美、林英夫、松本洋典、黒田純也、野村憲一、堀池重夫、島崎千尋、木村晋也、吉川敏一、谷脇雅史. 濾胞性リンパ腫に対するRituximabとCladribine併用療法の経験. 癌と化学療法. 34, 1623-1627, 2007.
• 船井典子、末岡榮三朗. 多発性骨髄腫における貧血. 治療. 89, 2450-2456, 2007.
• Kobayashi H, Kiyokawa M, Fukuoka M, Tanaka M, Fukuno Y, Aragane N, Hayashi S. A case of pulmonary artery pseudoaneurysm secondary to lung abscess. 日本呼吸器学会雑誌. 45, 627-630, 2007.
• 山口恵三, 館田一博, 中森祥隆, 柴山明義, 岩田敏, 松原敬太, 荘司路, 本間栄, 佐野剛, 村上日奈子, 濱崎雄平, 田代克弥, 林真一郎, 永沢善三, 泉信有, 仲剛, 土志田健, 蝶名林直彦, 内山伸, 杉浦秀子. LAMP法を用いたMycobacterium pneumoniae とLegionella spp.による呼吸器感染症の迅速診断試薬の評価. 医学と薬学. 58, 565-571, 2007.
• 中島崇裕，安福和弘，栗本典明，坂英雄，坪井正博，堀之内宏久，磯部宏，今村文生，大野康，佐藤雅美，土田敬明，栂博久，林真一郎，松井薫，宮澤 輝臣，横山晶，本田英俊，渋谷潔，藤澤武彦. 肺癌術前リンパ節転移診断におけるコンベックス走査式超音波気管支鏡ガイド下生検（EBUS-TBNA）の実際. 肺癌. 47, 207-214, 2007.

邦文総説

• 黒田純也、木村晋也. Ph陽性白血病～ABLキナーゼ変異検出と新規薬剤～. 血液フロンティア17: 19-29, 2007.
• 横田明日美、木村晋也、芦原英司、前川平. 変異ABLチロシンキナーゼを標的とした新規Ph白血病治療薬. Cancer Frontier 9: 137-145, 2007.
• 木村晋也. Ph陽性白血病治療におけるBCR-ABL変異検出の臨床的意義. Front Wave in Hematology 21: 8-9, 2007.
• 田中瑠璃子、木村晋也. Ph陽性白血病治療におけるBCR-ABL変異検出の臨床的意義＜変異BCR-ABLの検出方法＞. Front Wave in Hematology 22: 8-9, 2007.
• 上辻由里、木村晋也. イマチニブ耐性克服 －新たなチロシンキナーゼ阻害剤INNO-406－Biotherapy 4: 256-263, 2007.
• 木村晋也. Ph陽性白血病に対する新規チロシンキナーゼ阻害剤の開発状況. 血液・腫瘍科54: 710-718, 2007.
• 木村晋也. CMLに対する分子標的. 臨床血液 48: 46-55, 2007.
• 木村晋也. 新しい分子標的薬. 日本臨床 65: 46-51, 2007.
• 木村晋也. 新たなABLチロシンキナーゼ阻害剤. 医学のあゆみ 220: 783-788, 2007.

最終更新日：2014年10月1日